Creative Medical Technology Holdings Gross Profit Growth & History (CELZ)
Creative Medical Technology Holdings's gross profit was $3,806 for fiscal 2025.
View full Creative Medical Technology Holdings company overviewCreative Medical Technology Holdings annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3,806 | −$2,794 | −42.33% |
| 2024 | 2024-12-31 | $6,600 | $1,200 | +22.22% |
| 2023 | 2023-12-31 | $5,400 | −$54,709 | −91.02% |
| 2022 | 2022-12-31 | $60,109 | $20,304 | +51.01% |
| 2021 | 2021-12-31 | $39,805 | −$74,099 | −65.05% |
| 2020 | 2020-12-31 | $113,904 | −$6,097 | −5.08% |
| 2019 | 2019-12-31 | $120,001 | $65,976 | +122.12% |
| 2018 | 2018-12-31 | $54,025 | $57,225 | — |
| 2017 | 2017-12-31 | −$3,200 | −$3,200 | — |
| 2016 | 2016-12-31 | $0 | — | — |
Creative Medical Technology Holdings quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | −$1,800 | — |
| Q4 2025 | 2025-12-31 | $2,006 | $206 | +11.44% |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | −$4,800 | — |
| Q1 2025 | 2025-03-31 | $1,800 | $1,800 | — |
| Q4 2024 | 2024-12-31 | $1,800 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $0 | −$3,600 | — |
| Q2 2024 | 2024-06-30 | $4,800 | $4,800 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $1,800 | −$11,100 | −86.05% |
| Q3 2023 | 2023-09-30 | $3,600 | −$35,400 | −90.77% |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | −$8,209 | — |
| Q4 2022 | 2022-12-31 | $12,900 | −$15,405 | −54.43% |
| Q3 2022 | 2022-09-30 | $39,000 | $33,000 | +550.00% |
| Q2 2022 | 2022-06-30 | $0 | −$5,500 | — |
| Q1 2022 | 2022-03-31 | $8,209 | $8,209 | — |
| Q4 2021 | 2021-12-31 | $28,305 | $18,805 | +197.95% |
| Q3 2021 | 2021-09-30 | $6,000 | −$53,400 | −89.90% |
| Q2 2021 | 2021-06-30 | $5,500 | −$11,600 | −67.84% |
| Q1 2021 | 2021-03-31 | $0 | −$27,904 | — |
| Q4 2020 | 2020-12-31 | $9,500 | $17,960 | — |
| Q3 2020 | 2020-09-30 | $59,400 | $9,900 | +20.00% |
| Q2 2020 | 2020-06-30 | $17,100 | −$25,300 | −59.67% |
| Q1 2020 | 2020-03-31 | $27,904 | −$8,657 | −23.68% |
| Q4 2019 | 2019-12-31 | −$8,460 | −$37,008 | — |
| Q3 2019 | 2019-09-30 | $49,500 | $33,495 | +209.28% |
| Q2 2019 | 2019-06-30 | $42,400 | $40,128 | +1766.20% |
| Q1 2019 | 2019-03-31 | $36,561 | $29,361 | +407.79% |
| Q4 2018 | 2018-12-31 | $28,548 | $31,748 | — |
| Q3 2018 | 2018-09-30 | $16,005 | $16,005 | — |
| Q2 2018 | 2018-06-30 | $2,272 | $2,272 | — |
| Q1 2018 | 2018-03-31 | $7,200 | $7,200 | — |
| Q4 2017 | 2017-12-31 | −$3,200 | — | — |
| Q3 2017 | 2017-09-30 | $0 | — | — |
| Q2 2017 | 2017-06-30 | $0 | — | — |
| Q1 2017 | 2017-03-31 | $0 | — | — |
Creative Medical Technology Holdings gross profit trends
Over the last five fiscal years, Creative Medical Technology Holdings's gross profit decreased from $113,904 to $3,806, a change of −$110,098. The latest reported quarter, Q2 2026, shows $0.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Creative Medical Technology Holdings source filings ↗